Gravitas Education ADR Cl. A Aktie

Highlights Include Sale of a Non-strategic Business Unit, Significant Reduction of Debt, and Implementation of a Share Repurchase Program to Strengthen the Company and Enhance Long Term Shareholder Value  SEATTLE , March 26, 2025 /PRNewswire/ -- Mynd.ai, Inc. (the "Company" or "Mynd") (NYSE American: MYND) today announced financial results for the fiscal year ended December 31, 2024. Revenue of $267.4 million for the full year, compared to $411.8 million in the prior year with the decrease primarily driven by the headwinds in the overall education market due to normalization to pre-pandemic levels Gross Margin improved 40 basis points versus 2023 to 24.8%, largely due to optimization of cost of materials, warranty, and freight costs Operating loss improved by $8.0 million to $38.0 million, as compared to $46.0 million in 2023 Net loss from continuing operations, before income taxes totaled $35.7 million, a $12.7 million improvement compared to 2023 Cash balance at year-end of $75.3 million, compared to $87.8 million in 2023 Reduced outstanding indebtedness at year-end by $21.0 million Repurchased 151,923 American Depositary Shares, representing 1,519,230 ordinary shares, pursuant to our share repurchase program "We are very pleased with the progress our team made during 2024, our first full year as a public company," said Vin Riera, Chief Executive Officer.» Mehr auf prnewswire.com

The company was recognized in the Secondary category for its dynamic Explain Everything Advanced lesson creation and delivery software for K-12 schools and students SEATTLE , March 6, 2025 /PRNewswire/ -- Promethean, a leading global tech company and brand owned by Mynd.ai, Inc. (NYSE American: MYND), won this year's Tech & Learning Awards of Excellence: Best of 2024 in the Secondary category from Tech & Learning magazine. The Tech & Learning Awards of Excellence team appoints a panel of judges to seek out innovative products offering school districts flexibility, value, and tailored solutions to help solve difficulties including decreased budget, less engaged students, and sustainable edtech options.» Mehr auf prnewswire.com

Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - MYND Life Sciences Inc. (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the development and commercialization of drug therapies and diagnostics to improve the monitoring and treatment of depression, today announced that it has entered into shares for debt agreements (the "Agreements"), to satisfy an aggregate of $2,273,062.30 of the Company's outstanding debt (the "Indebtedness") related to loan, fees including all principal, accrued and unpaid interest, costs payments outstanding. An aggregate of 22,730,623 common shares in the capital of the Company (the "Shares") at a deemed price of $0.10 per Share are proposed to be issued to the creditors.» Mehr auf newsfilecorp.com